Functional comparison of anaesthetic agents during myocardial ischaemia-reperfusion using pressure-volume loops

British Journal of Anaesthesia

Volumn 103, Issue 5, 2009, Pages 654-664

  Andrews, D T ^a,b   Royse, A G ^a,b   Royse, C F ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Anaesthetics i.v., propofol; Anaesthetics volatile; Heart, ischaemia; Research, anaesthesia

Indexed keywords

DESFLURANE; FRESOFOL; PROPOFOL; SEVOFLURANE; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; HEART HEMODYNAMICS; HEART INDEX; HEART INFARCTION SIZE; HEART LEFT VENTRICLE COMPLIANCE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE RELAXATION; HEART MUSCLE REPERFUSION; HEART PRELOAD; HEART PROTECTION; HEART RATE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; RABBIT; SYSTEMIC VASCULAR RESISTANCE;

EID: 74949112448     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aep238     Document Type: Article

References (35)

1. De Hert SG, Turani F, Mathur S, Stowe DF. Cardioprotection with volatile anesthetics: mechanisms and clinical implications. Anesth Analg 2005; 100: 1584-1593
2. Javadov SA, Lim KH, Kerr PM, Suleiman MS, Angelini GD, Halestrap AP. Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc Res 2000; 45: 360-369
3. Ko SH, Yu CW, Lee SK, et al.. Propofol attenuates ischemia- reperfusion injury in the isolated rat heart. Anesth Analg 1997; 85: 719-724
4. Xia Z, Huang Z, Ansley DM. Large-dose propofol during cardiopulmonary bypass decreases biochemical markers of myocardial injury in coronary surgery patients: a comparison with isoflurane. Anesth Analg 2006; 103: 527-532
5. Burkhoff D, Mirsky I, Suga H. Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. Am J Physiol Heart Circ Physiol 2005; 289: H501-12
6. Royse CF, Liew DF, Wright CE, Royse AG, Angus JA. Persistent depression of contractility and vasodilation with propofol but not with sevoflurane or desflurane in rabbits. Anesthesiology 2008; 108: 87-93
7. Doorley BM, Waters SJ, Terrell RC, Robinson JL. MAC of I-653 in beagle dogs and New Zealand white rabbits. Anesthesiology 1988; 69: 89-91
8. Scheller MS, Saidman LJ, Partridge BL. MAC of sevoflurane in humans and the New Zealand white rabbit. Can J Anaesth 1988; 35: 153-156
9. Eger EI II. Age, minimum alveolar anesthetic concentration, and minimum alveolar anesthetic concentration-awake. Anesth Analg 2001; 93: 947-953
10. Plummer GF. Improved method for the determination of propofol in blood by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987; 421: 171-176
11. Andrews DT, Leslie K, Sessler DI, Bjorksten AR. The arterial blood propofol concentration preventing movement in 50% of healthy women after skin incision. Anesth Analg 1997; 85: 414-419
12. Khalil PN, Siebeck M, Huss R, et al.. Histochemical assessment of early myocardial infarction using 2,3,5-triphenyltetrazolium chloride in blood-perfused porcine hearts. J Pharmacol Toxicol Methods 2006; 54: 307-312
13. Klein HH, Shaper J, Shaper W. The mechanism of the tetrazolium reaction in identifying experimental myocardial infarction. Virchows Archiv 1981; 393: 287-297
14. Ludbrook J. Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc Res 1994; 28: 303-311
15. Lindstedt L, Schaeffer PJ. Use of allometry in predicting anatomical and physiological parameters of mammals. Lab Anim 2002; 36: 1-19
16. Aeschbacher G, Webb AI. Propofol in rabbits. 2. Long-term anesthesia. Lab Anim Sci 1993; 43: 328-335
17. Orszulak-Michalak D. The influence of selected antiarrhythmic drugs on the hemodynamic parameters in rabbits during anesthesia. Part I. Propofol anesthesia. Pol J Pharmacol 1995; 47: 143-152
18. Hu Q, Wang X, Lee J, et al.. Profound bioenergetic abnormalities in peri-infarct myocardial regions. Am J Physiol Heart Circ Physiol 2006; 291: H648-57
19. Varma N, Eberli FR, Apstein CS. Left ventricular diastolic dysfunction during demand ischemia: rigor underlies increased stiffness without calcium-mediated tension. Amelioration by glycolytic substrate. J Am Coll Cardiol 2001; 37: 2144-2153
20. Pagel PS, Hettrick DA, Lowe D, Tessmer JP, Warltier DC. Desflurane and isoflurane exert modest beneficial actions on left ventricular diastolic function during myocardial ischemia in dogs. Anesthesiology 1995; 83: 1021-1035
21. Piriou V, Chiari P, Lhuillier F, et al.. Pharmacological preconditioning: comparison of desflurane, sevoflurane, isoflurane and halothane in rabbit myocardium. Br J Anaesth 2002; 89: 486-491
22. Preckel B, Mullenheim J, Hoff J, et al.. Haemodynamic changes during halothane, sevoflurane and desflurane anaesthesia in dogs before and after the induction of severe heart failure. Eur J Anaesthesiol 2004; 21: 797-806
23. Preckel B, Schlack W, Comfere T, Obal D, Barthel H, Thamer V. Effects of enflurane, isoflurane, sevoflurane and desflurane on reperfusion injury after regional myocardial ischaemia in the rabbit heart in vivo. Br J Anaesth 1998; 81: 905-912 (Pubitemid 28561325)
24. De Hert SG, Van Der Linden PJ, Cromheecke S, et al.. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 2004; 101: 299-310
25. Cope DK, Impastato WK, Cohen MV, Downey JM. Volatile anesthetics protect the ischemic rabbit myocardium from infarction. Anesthesiology 1997; 86: 699-709
26. De Hert SG, Cromheecke S, Ten Broecke PW, et al.. Effects of propofol, desflurane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients. Anesthesiology 2003; 99: 314-323
27. De Hert SG, ten Broecke PW, Mertens E, et al.. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 2002; 97: 42-49
28. De Hert SG, Van Der Linden PJ, Cromheecke S, et al.. Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass. Anesthesiology 2004; 101: 9-20
29. Shao H, Li J, Zhou Y, et al.. Dose-dependent protective effect of propofol against mitochondrial dysfunction in ischaemic/reperfused rat heart: role of cardiolipin. Br J Pharmacol 2008; 153: 1641-1649
30. Lucchinetti E, Hofer C, Bestmann L, et al.. Gene regulatory control of myocardial energy metabolism predicts postoperative cardiac function in patients undergoing off-pump coronary artery bypass graft surgery: inhalational versus intravenous anesthetics. Anesthesiology 2007; 106: 444-457
31. Morgan DJ, Campbell GA, Crankshaw DP. Pharmacokinetics of propofol when given by intravenous infusion. Br J Clin Pharmacol 1990; 30: 144-148
32. Cockshott ID, Douglas EJ, Plummer GF, Simons PJ. The pharmacokinetics of propofol in laboratory animals. Xenobiotica 1992; 22: 369-375
33. Perez-Martinez A, Gonzalvez-Pinera J, Marco-Macian A, Carpintero-Moreno F, Moya-Marchante M. Propofol in continuous perfusion as anesthetic in experimental surgery in the rabbit. Rev Esp Anestesiol Reanim 1995; 42: 253-256
34. Van Leeuwen AF, Evans RG, Ludbrook J. Effects of halothane, ketamine, propofol and alfentanil anaesthesia on circulatory control in rabbits. Clin Exp Pharmacol Physiol 1990; 17: 781-798
35. Watts AD, Eliasziw M, Gelb AW. Propofol and hyperventilation for the treatment of increased intracranial pressure in rabbits. Anesth Analg 1998; 87: 564-568